Come up with a name for your new list and we'll add to it:
Kalion raised a round of funding on March 10, 2017. Investors include
Cherrystone Angel Group.
Kalion is an early stage industrial biotech company is focused on providing low-cost access to glucaric acid and S-3-hydroxybutyrolactone (3-HBL) using traditional, green, fermentation technology.…